Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naama Yekutiel

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|January 12, 2021
The effects of continuous glucose monitoring system on patient outcomes and associated costs in a real-world settingNoa Triki, Naama Yekutiel, Lilly Levi, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 15, 2021
Long-Term Follow-Up of Denosumab Discontinuers with Multiple Vertebral Fractures in the Real-World: A Case SeriesLiana Tripto-Shkolnik, Yair Liel, Naama Yekutiel, et al.
Journal of Human Hypertension|August 23, 2022
Resistant hypertension is associated with an increased cardiovascular risk compared to patients controlled on a similar multi-drug regimenAdi Leiba, Naama Yekutiel, Gabriel Chodick, et al.
Frontiers in Cardiovascular Medicine|May 18, 2026
Treatment patterns and adherence to lipid-lowering therapy, LDL-C control, clinical outcomes, and healthcare resource utilization in treated patients with hypercholesterolemia at high cardiovascular risk in Israel: a retrospective database studyMatan Azulay, Naama Yekutiel, Moran Elboim, et al.
Leukemia & Lymphoma|June 8, 2021
Diabetes, but not pre-diabetes, is associated with shorter time to second-line therapy and worse outcomes in patients with multiple myelomaIrit Avivi, Naama Yekutiel, Inbar Cohen, et al.
Neurogastroenterology and Motility|January 20, 2023
The epidemiology and burden of gastroparesis: Real-world data from a large healthcare provider in IsraelNaama Yekutiel, Gabriel Chodick, Jana Knop, et al.
Pediatric Pulmonology|March 3, 2021
Respiratory morbidity in very low birth weight infants through childhood and adolescenceYoav Littner, Chen Volinsky, Jacob Kuint, et al.
Annals of Hematology|August 30, 2023
Management and outcome of 500 multiple myeloma patients treated for first relapse outside clinical studiesIrit Avivi, Naama Yekutiel, Tamir Shragai, et al.
Journal of Clinical Medicine|June 27, 2024
Clinical and Economic Implications of Hydroxyurea Intolerance in Polycythemia Vera in Routine Clinical PracticeMartin H Ellis, Tamar Tadmor, Naama Yekutiel, et al.
The Lancet. Diabetes & Endocrinology|January 13, 2022
Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate dataDianna J Magliano, Lei Chen, Bendix Carstensen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Diabetic Medicine : a Journal of the British Diabetic Association|January 12, 2021
The effects of continuous glucose monitoring system on patient outcomes and associated costs in a real-world settingNoa Triki, Naama Yekutiel, Lilly Levi, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 15, 2021
Long-Term Follow-Up of Denosumab Discontinuers with Multiple Vertebral Fractures in the Real-World: A Case SeriesLiana Tripto-Shkolnik, Yair Liel, Naama Yekutiel, et al.
Journal of Human Hypertension|August 23, 2022
Resistant hypertension is associated with an increased cardiovascular risk compared to patients controlled on a similar multi-drug regimenAdi Leiba, Naama Yekutiel, Gabriel Chodick, et al.
Frontiers in Cardiovascular Medicine|May 18, 2026
Treatment patterns and adherence to lipid-lowering therapy, LDL-C control, clinical outcomes, and healthcare resource utilization in treated patients with hypercholesterolemia at high cardiovascular risk in Israel: a retrospective database studyMatan Azulay, Naama Yekutiel, Moran Elboim, et al.
Leukemia & Lymphoma|June 8, 2021
Diabetes, but not pre-diabetes, is associated with shorter time to second-line therapy and worse outcomes in patients with multiple myelomaIrit Avivi, Naama Yekutiel, Inbar Cohen, et al.
Neurogastroenterology and Motility|January 20, 2023
The epidemiology and burden of gastroparesis: Real-world data from a large healthcare provider in IsraelNaama Yekutiel, Gabriel Chodick, Jana Knop, et al.
Pediatric Pulmonology|March 3, 2021
Respiratory morbidity in very low birth weight infants through childhood and adolescenceYoav Littner, Chen Volinsky, Jacob Kuint, et al.
Annals of Hematology|August 30, 2023
Management and outcome of 500 multiple myeloma patients treated for first relapse outside clinical studiesIrit Avivi, Naama Yekutiel, Tamir Shragai, et al.
Journal of Clinical Medicine|June 27, 2024
Clinical and Economic Implications of Hydroxyurea Intolerance in Polycythemia Vera in Routine Clinical PracticeMartin H Ellis, Tamar Tadmor, Naama Yekutiel, et al.
The Lancet. Diabetes & Endocrinology|January 13, 2022
Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate dataDianna J Magliano, Lei Chen, Bendix Carstensen, et al.
Pageof 2